A Retrospective Study to Evaluate the Predictability of Abnormal Arterial Blood Gas Measurements Through Novel Observations of Continuous Trends in Electronically Measured Respiratory Rate in a Mixed Cohort of Respiratory Compromised Patients
1 other identifier
observational
322
1 country
1
Brief Summary
A retrospective study to evaluate the predictability of abnormal arterial blood gas measurements through novel observations of continuous trends in electronically measured respiratory in a mixed cohort of respiratory compromised patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 12, 2021
CompletedFirst Submitted
Initial submission to the registry
May 17, 2022
CompletedFirst Posted
Study publicly available on registry
May 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 12, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 12, 2022
CompletedMay 20, 2022
May 1, 2022
1.3 years
May 17, 2022
May 19, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive Predictive Value/Precision (PPV)
Positive Predictive Value/Precision (PPV) of an elevated RespiraSense monitoring Respiratory Rate (RR) for an abnormal ABG - for a single disease state (COPD)
12 months
Secondary Outcomes (1)
PPV of an elevated RR for an abnormal ABG - for a mix of disease states
12 months
Other Outcomes (1)
PPV of elevated RR
6 months
Study Arms (2)
COPD
Patients admitted with COPD as the primary admission.
Respiratory Compromised General
Patients admitted with Pneumonia, COPD, COVID, to be included
Interventions
The use of continuous electronic monitoring of respiratory rate
Eligibility Criteria
Acutely admitted respiratory compromised patients in a hospital setting
You may qualify if:
- Respiratory condition is the primary admission diagnosis
You may not qualify if:
- Pregnant patients in their 2nd or 3rd trimester
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Beaumont Hospital
Dublin, Ireland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Respiratory Medicine
Study Record Dates
First Submitted
May 17, 2022
First Posted
May 20, 2022
Study Start
July 12, 2021
Primary Completion
October 12, 2022
Study Completion
December 12, 2022
Last Updated
May 20, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share
IPD will not be made available.